<DOC>
	<DOC>NCT00993863</DOC>
	<brief_summary>The objective of this study is to evaluate the analgesic efficacy and safety of ADL5859 compared with placebo and an active control (ibuprofen) in subjects with acute dental pain after third molar extraction.</brief_summary>
	<brief_title>Analgesic Efficacy and Safety of ADL5859 in Subjects With Acute Dental Pain After Third Molar Extraction</brief_title>
	<detailed_description />
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Key have 2 or more 3rd molars requiring extraction, including at least 1 partially or completely boneimpacted mandibular molar experience moderate to severe pain intensity as measured by the Numeric Pain Rating Scale (NPRS) (score â‰¥ 5) within 6 hours after surgery for male subjects, be surgically sterile or agree to use an appropriate method of contraception or have a sexual partner who is surgically sterile or using an insertable, injectable, transdermal, or combination oral contraceptive for female subjects, be using contraceptives, be postmenopausal, or have undergone hysterectomy or tubal ligation be able to take oral study medications Key have positive results either on the urine screening tests for opiates, tetrahydrocannabinol,cocaine, amphetamines, barbiturates, benzodiazepines, phencyclidine, or propoxyphene or on the alcohol breathalyzer test have a history of alcoholism or drug addiction or abuse within 5 years before dosing with study medication have a history of chronic use (defined as daily use for &gt; 2 weeks) of glucocorticoids,nonsteroidal antiinflammatory drugs, or opiates for any condition within 6 months of study medication administration have a known allergy or history of significant reaction to any of the known treatment medications (ADL5859like compounds or ibuprofen) or rescue pain medication (acetaminophen) have significant renal or hepatic disease, as indicated by clinical laboratory assessment have a known history of epilepsy or seizure disorder, including history of febrile seizure, or any other medical or psychiatric condition that, in the judgment of the investigator, would put the subject at risk while in the study, could influence the results of the study, or could negatively affect the subject's ability to participate in the study have a history or evidence of orthostatic hypotension at screening have a history of significant head trauma (head injury with loss of consciousness)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>delta opioid agonist</keyword>
	<keyword>dental pain</keyword>
</DOC>